Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis (NCT03009357) | Clinical Trial Compass
CompletedNot Applicable
Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis
South Korea40 participantsStarted 2016-11
Plain-language summary
The study is a single-center prospective cohort study of clinical application of continuously monitored data by wearable activity trackers in the patients with thyrotoxicosis. The purpose of the study is to evaluate the association between parameters of pulse rate, activity, and sleep from wearable activity trackers and the thyrotoxic status along with the treatment.
Who can participate
Age range
20 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients undergoing newly developed or recurrent thyrotoxicosis who are treated and followed-up in Seoul National University Bundang Hospital
* Patients who can use wearable activity trackers and smartphone applications
* In case of Graves' disease, patients who will treated by anti-thyroid drugs
Exclusion Criteria:
* Patients who have thyrotoxic periodic paralysis
* In case of Graves' disease, patients who will treated by radioactive iodine therapy or thyroidectomy
* Patients who have thyrotoxicosis due to toxic nodular disease
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study tracked pulse rate, physical activity, and sleep using a wearable device in people with thyrotoxicosis — could wearing an activity tracker like this help my own doctor monitor how well my thyroid treatment is working between appointments?
2Since this trial is completed, have the results been published, and if so, what did they find about how wearable tracker data lines up with actual thyroid hormone levels or symptom severity?
3My condition affects my heart rate and sleep, which is exactly what this study was measuring — based on what this research found, would it make sense for me to start tracking my pulse rate and sleep at home right now as part of my care?
4This was a monitoring study rather than a treatment trial, so it wasn't testing a new drug or procedure — does that mean my standard treatment options like antithyroid medications or radioactive iodine are still the most proven paths, and how would participating in something like this fit alongside those?
5If wearable trackers can reflect how thyrotoxic someone is, could my doctor use data from a consumer device I already own — like a smartwatch — to make more informed decisions about adjusting my treatment?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Association between parameters of pulse rate, activity, and sleep from wearable activity trackers and the thyrotoxic status
Timeframe: continuous monitoring through the study period (average 3 months)